Quantcast

Latest Diabetic retinopathy Stories

2014-04-01 16:25:30

Welch brings more than 25 years of leadership and global healthcare industry expertise to IRIS as the company expands its regional and national footprint PENSACOLA, Fla., April 1, 2014 /PRNewswire/ -- IRIS: Intelligent Retinal Imaging Systems, the country's preeminent cloud-based retinal screening technology provider, announced today that Pat Welch has joined its leadership team as Vice President of Healthcare Accounts. "Pat brings to the IRIS team more than 25 years of in-depth,...

2014-03-26 11:32:37

New research in the FASEB Journal suggests that the complement system allows the body to identify abnormal vessels and specifically target them for removal without damaging healthy cells A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens. It also helps...

2014-03-24 12:30:49

LONDON, March 24, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analysis of the US Retinal Therapeutics Market Improvements in Administration and Efficacy Drive GrowthSince the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research...

2014-03-10 04:21:04

LEUVEN, Belgium, March 10, 2014 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a EUR3 million grant from the Flemish agency for Innovation by Science and Technology (IWT). The grant funding will be used by ThromboGenics to support research into potential new biotherapeutics for the...

2014-03-06 08:29:58

DALLAS, March 6, 2014 /PRNewswire-iReach/ -- ReportsnReports.com adds "U.S. Market for Diagnostic Opthalmic Devices" & "U.S. Market and Survey for Retinopathy Screening Devices" reports to its research database. (Photo: http://photos.prnewswire.com/prnh/20140306/MN77154) The market for diagnostic ophthalmic devices continues to expand, driven by strong growth in revenue from optical coherence tomographers (OCTs). In 2013, the market for diagnostic ophthalmic devices continued...

2014-03-05 08:28:36

VANCOUVER, March 5, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) has announced the final month eight patient visit in the iDEAL Study. This US Phase 2 investigator-sponsored study is evaluating the efficacy and safety of iCo-007 after repeated injections in patients with Diabetic Macular Edema (DME). The study's primary endpoint is change in visual acuity from baseline to month eight, followed by secondary endpoints at month...

2014-03-03 04:22:41

TARRYTOWN, N.Y., March 3, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA(®) (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare (MHLW). "Clinically significant DME is a leading cause of vision loss in the working-age...

2014-02-24 23:03:11

Weil Eye Care urges patients to get an eye exam during Save Your Vision Month. San Carlos, CA (PRWEB) February 24, 2014 In honor of Save Your Vision Month, Weil Eye Care is offering tips and information on maintaining good eye and vision health. The most important tip to remember is to schedule regular eye exams. Weil Eye Care highly recommends that everyone make an appointment for an eye exam regularly. Getting an eye exam is an essential step in preserving vision and keeping eyes...

2014-02-24 08:27:50

TARRYTOWN, N.Y., Feb. 24, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from...

Exercise Can Help Reduce Or Slow Vision Loss
2014-02-12 12:23:58

Brett Smith for redOrbit.com - Your Universe Online While it may seem unrelated to eye function, physical exercise can actually help to protect the structure and function of nerve cells in the retina after injury – according to a new study in The Journal of Neuroscience. The study indicated that exercising may be able to hamper the advancement of retinal degenerative diseases, such as age-related macular degeneration. “This is the first report of simple exercise having a direct...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related